Corticosteroid compounds (group 3, potent) Organon Pharma

Diprosalic Ointment

Diprosalic contains betamethasone dipropionate, a synthetic fluorinated corticosteroid equivalent to 0.05% betamethasone. It also contains 3% salicylic acid. It is active topically, and produces a rapid and sustained response in inflammatory dermatoses that normally respond to topical corticosteroid therapy. It is also effective in less responsive conditions, such as psoriasis of the scalp and chronic plaque psoriasis of the hands and feet, but not in widespread plaque psoriasis. Topical salicylic acid softens keratin, loosens cornified epithelium and desquamates the epidermis allowing more rapid access to the dermis than when applying steroid alone.

Indications

For the treatment of hyperkeratotic and dry corticosteroid-responsive dermatoses where the cornified epithelium may resist penetration of the steroid.

Price

30g, £3.18
100g, £9.14

Corticosteroid compounds (group 3, potent)

All Corticosteroid compounds (group 3, potent)

LEO Pharma

Fucibet Cream

Fucibet Cream combines the well-known anti-inflammatory and antipruritic effects of betamethasone with the topical antibacterial action of fusidic acid. Betamethasone valerate is a topical steroid that is rapidly effective in inflammatory dermatoses that normally respond to this form of therapy. More refractory conditions can often be treated successfully. When applied topically, fusidic acid is effective against Staphylococcus aureus, Streptococcus, Corynebacterium, Neisseria and certain clostridia and Bacteroides. Concentrations of 0.03-0.12µg per ml inhibit nearly all strains of S. aureus. The antibacterial activity of fusidic acid is not diminished in the presence of betamethasone

LEO Pharma

Fucibet Lipid Cream

Fucibet Lipid Cream combines the well-known anti-inflammatory and antipruritic effects of betamethasone with the topical antibacterial action of fusidic acid. Betamethasone valerate is a topical steroid that is rapidly effective in inflammatory dermatoses that normally respond to this form of therapy. More refractory conditions can often be treated successfully. When applied topically, fusidic acid is effective against Staphylococcus aureus, Streptococcus, Corynebacterium, Neisseria and certain clostridia and Bacteroides. Concentrations of 0.03-0.12µ per ml inhibit nearly all strains of S. aureus. The antibacterial activity of fusidic acid is not diminished in the presence of betamethasone